Atea Pharmaceuticals Balance Sheet (2019-2026) | AVIR

Balance Sheet Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Accumulated Depreciation (Quarter)
0.16M0.27M0.69M1.10M1.52M
Assets
Current Assets
Cash & Equivalents (Quarter)
816.46M839.66M764.38M705.54M684.48M176.41M188.46M183.25M213.70M137.89M143.82M160.91M494.71M474.99M451.01M119.39M87.72M77.34M95.71M79.32M
Receivables - Net (Quarter)
50.00M4.51M
Receivables - Other (Quarter)
Receivables (Quarter)
50.00M4.51M
Prepaid Assets (Quarter)
4.65M3.29M8.03M7.69M4.97M12.45M14.21M11.90M12.76M8.19M12.35M7.27M4.16M4.09M7.63M8.27M5.89M6.83M9.16M7.19M
Current Assets (Quarter)
871.11M842.95M772.40M713.23M689.45M681.93M660.92M632.39M620.83M603.32M590.46M548.76M506.37M486.91M462.36M433.71M385.60M336.14M310.99M263.20M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
0.03M0.03M0.02M0.76M1.90M1.81M1.71M1.60M1.50M1.39M1.29M1.19M1.08M0.98M0.87M0.77M0.67M0.56M0.46M0.35M
Other Non-Current Assets (Quarter)
0.11M0.30M0.30M0.30M0.30M0.30M0.20M0.20M0.20M1.40M1.40M1.40M1.40M1.68M0.20M4.39M4.39M5.47M3.14M3.05M
Non-Current Assets (Quarter)
0.43M0.56M0.49M3.96M4.89M4.64M5.79M5.74M5.20M4.76M4.51M4.26M4.01M4.05M2.31M6.26M6.00M6.83M4.23M3.88M
Assets (Quarter)
871.54M843.50M772.89M717.19M694.34M686.58M666.71M638.13M626.03M608.08M594.97M553.03M510.38M490.96M464.67M439.96M391.61M342.96M315.22M267.08M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
10.70M22.19M4.53M3.66M13.88M1.12M2.55M0.70M3.96M0.40M4.25M21.14M5.47M5.79M4.46M7.39M8.84M3.52M12.95M9.45M
Payables (Quarter)
10.70M22.19M4.53M3.66M13.88M1.12M2.55M0.70M3.96M0.40M4.25M21.14M5.47M5.79M4.46M7.39M8.84M3.52M12.95M9.45M
Accumulated Expenses (Quarter)
37.96M47.68M52.15M1.91M3.22M13.80M15.21M10.93M11.46M17.75M5.70M19.41M20.37M18.61M5.90M2.85M3.72M4.89M6.44M2.27M
Current Leases (Quarter)
0.20M0.11M0.73M0.71M0.72M0.73M0.74M0.75M0.76M0.77M0.78M0.79M0.80M0.81M0.82M0.83M0.84M0.63M
Current Taxes (Quarter)
7.20M12.00M2.57M2.57M0.01M0.71M0.10M0.18M0.02M
Current Deferred Revenue (Quarter)
224.99M192.18M
Total Current Liabilities (Quarter)
273.65M262.05M56.88M28.61M25.11M15.63M18.48M12.36M16.16M18.89M32.38M41.31M26.62M25.19M18.60M21.75M20.12M20.18M39.78M33.37M
Non-Current Liabilities
Preferred Stock Liabilities (Quarter)
Operating Leases (Quarter)
2.76M2.77M2.58M2.40M2.21M2.03M1.83M1.64M1.45M1.25M1.04M0.84M0.63M0.42M0.21M
Other Non-Current Liabilities (Quarter)
0.03M5.93M5.93M6.01M5.17M5.25M5.37M5.49M5.62M5.76M5.90M6.05M6.20M6.36M6.50M6.64M6.79M
Total Non-Current Liabilities (Quarter)
273.65M56.88M31.37M27.87M18.22M20.88M14.58M18.18M20.73M34.02M42.76M27.86M26.23M19.45M22.38M20.54M20.39M39.78M
Total Liabilities (Quarter)
273.68M262.05M62.81M37.30M33.88M23.39M26.14M19.95M23.68M26.34M39.78M48.66M33.91M32.44M25.80M28.88M27.19M27.18M39.78M33.37M
Shareholder's Equity
Common Equity (Quarter)
597.86M581.45M710.08M679.88M660.46M663.19M640.57M618.18M602.35M581.73M555.19M504.37M476.47M458.52M438.87M411.08M364.42M315.78M275.43M233.71M
Shareholder's Equity (Quarter)
597.86M581.45M710.08M679.88M660.46M663.19M640.57M618.18M602.35M581.73M555.19M504.37M476.47M458.52M438.87M411.08M364.42M315.78M275.43M233.71M
Liabilities and Shareholders Equity (Quarter)
871.54M843.50M772.89M717.19M694.34M686.58M666.71M638.13M626.03M608.08M594.97M553.03M510.38M490.96M464.67M439.96M391.61M342.96M315.22M267.08M
Retained Earnings (Quarter)
-32.91M-61.10M56.03M13.95M-17.38M-25.45M-0.68M-95.35M-123.53M-156.67M-195.84M-0.18M-0.28M0.64M-364.22M-398.49M0.04M0.24M-522.57M-0.10M
Treasury Shares (Quarter)
0.72M2.15M2.34M2.34M0.72M2.56M1.78M1.78M1.78M2.47M2.47M3.05M2.47M3.99M
Shares Outstanding (Quarter)
82.78M83.05M83.10M83.26M83.26M83.29M83.29M83.40M83.40M83.44M83.44M84.22M84.42M84.46M84.46M85.58M81.14M78.13M78.13M80.03M